Literature DB >> 22051280

Geographic distance between donor and recipient does not influence outcomes after lung transplantation.

Sara A Hennessy1, Tjasa Hranjec, Abbas Emaminia, Damien J Lapar, Benjamin D Kozower, Irving L Kron, David R Jones, Christine L Lau.   

Abstract

BACKGROUND: The shortage in organ donation is a major limiting factor for patients with end-stage lung disease. Expanding the donor pool would be beneficial. We investigated the importance of geographic distance between the donor and recipient and hypothesized that it would not be a critical determinant of outcomes after lung transplantation.
METHODS: We retrospectively reviewed the United Network for Organ Sharing lung transplant database from 2000 to 2005 to allow sufficient time for bronchiolitis obliterans syndrome (BOS) development. Allograft recipients were stratified by geographic distance from their donors (local, regional, and national) and had yearly follow-up. The primary end points were the development of BOS and 1-year and 3-year mortality. Posttransplant outcomes were compared using a multivariable Cox proportional hazard model. Kaplan-Meier curves were compared by log-rank test.
RESULTS: Of 6,055 allograft recipients, donors were local in 59%, regional in 19.3%, and national in 21.7%. BOS-free survival did not differ by geographic distance. Geographic distance did not independently predict BOS (hazard ratio, 1.03; 95% confidence interval, 0.96 to 1.10). Similarly, Kaplan-Meier survival curves were not significantly worse for recipients with national donors. Geographic distance did not independently predict 3-year mortality (hazard ratio, 0.95; 95% confidence interval, 0.89 to 1.01).
CONCLUSIONS: With appropriate donor selection, moderately long geographic distance (average ischemic time < 6 hours) between the donor and recipient is not associated with the development of BOS or increased death after lung transplantation. By placing less emphasis on distance, more donors could potentially be used to expand the donor pool. Copyright Â
© 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22051280      PMCID: PMC3470835          DOI: 10.1016/j.athoracsur.2011.06.086

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

1.  Low-potassium dextran preservation solution improves lung function after human lung transplantation.

Authors:  S Fischer; A Matte-Martyn; M De Perrot; T K Waddell; Y Sekine; M Hutcheon; S Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2001-03       Impact factor: 5.209

2.  Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation.

Authors:  Takahiro Oto; Anne P Griffiths; Franklin Rosenfeldt; Bronwyn J Levvey; Trevor J Williams; Gregory I Snell
Journal:  Ann Thorac Surg       Date:  2006-11       Impact factor: 4.330

3.  Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience.

Authors:  Marc De Perrot; Thomas K Waddell; Yaron Shargall; Andrew F Pierre; Elie Fadel; Karl Uy; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Shaf Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12-29       Impact factor: 5.209

4.  Influence of graft ischemic time on outcomes following lung transplantation.

Authors:  S M Fiser; I L Kron; S M Long; A K Kaza; J A Kern; D C Cassada; D R Jones; M C Robbins; C G Tribble
Journal:  J Heart Lung Transplant       Date:  2001-12       Impact factor: 10.247

5.  Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours.

Authors:  T L Winton; J D Miller; A deHoyos; G Snell; J Maurer
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

6.  Influence of graft ischemic time and donor age on survival after lung transplantation.

Authors:  R J Novick; L E Bennett; D M Meyer; J D Hosenpud
Journal:  J Heart Lung Transplant       Date:  1999-05       Impact factor: 10.247

7.  Graft ischemic time and outcome of lung transplantation: a multicenter analysis.

Authors:  Gabriel Thabut; Hervé Mal; Jacques Cerrina; Philippe Dartevelle; Claire Dromer; Jean-François Velly; Marc Stern; Philippe Loirat; Guy Lesèche; Michelle Bertocchi; Jean-François Mornex; Alain Haloun; Philippe Despins; Christophe Pison; Dominique Blin; Martine Reynaud-Gaubert
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

Review 8.  Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques--non-heart-beating donor lung retrieval and ex vivo donor lung perfusion.

Authors:  Jonathan C Yeung; Marcelo Cypel; Thomas K Waddell; Dirk van Raemdonck; Shaf Keshavjee
Journal:  Thorac Surg Clin       Date:  2009-05       Impact factor: 1.750

9.  Does donor organ ischemia over four hours affect long-term survival after lung transplantation?

Authors:  V R Kshettry; T J Kroshus; J Burdine; K Savik; R M Bolmon
Journal:  J Heart Lung Transplant       Date:  1996-02       Impact factor: 10.247

10.  Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Sara A Hennessy; Tjasa Hranjec; Brian R Swenson; Benjamin D Kozower; David R Jones; Gorav Ailawadi; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

View more
  6 in total

1.  Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Authors:  Hrishikesh S Kulkarni; Wida S Cherikh; Daniel C Chambers; Victoria C Garcia; Ramsey R Hachem; Daniel Kreisel; Varun Puri; Benjamin D Kozower; Derek E Byers; Chad A Witt; Jennifer Alexander-Brett; Patrick R Aguilar; Laneshia K Tague; Yuka Furuya; G Alec Patterson; Elbert P Trulock; Roger D Yusen
Journal:  J Heart Lung Transplant       Date:  2018-09-25       Impact factor: 10.247

2.  Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality.

Authors:  D Hayes; M G Hartwig; J D Tobias; D Tumin
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

3.  Contemporary Issues in Lung Transplant Allocation Practices.

Authors:  Wayne M Tsuang
Journal:  Curr Transplant Rep       Date:  2017-07-21

Review 4.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

5.  Current State of Pediatric Lung Transplantation.

Authors:  Don Hayes; Christian Benden; Stuart C Sweet; Carol K Conrad
Journal:  Lung       Date:  2015-08-04       Impact factor: 2.584

6.  A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.S.

Authors:  Darren E Stewart; Dallas W Wood; James B Alcorn; Erika D Lease; Michael Hayes; Brett Hauber; Rebecca E Goff
Journal:  BMC Med Inform Decis Mak       Date:  2021-01-06       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.